186 related articles for article (PubMed ID: 34652144)
1. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.
Cramer J; Lakkaichi A; Aliu B; Jakob RP; Klein S; Cattaneo I; Jiang X; Rabbani S; Schwardt O; Zimmer G; Ciancaglini M; Abreu Mota T; Maier T; Ernst B
J Am Chem Soc; 2021 Oct; 143(42):17465-17478. PubMed ID: 34652144
[TBL] [Abstract][Full Text] [Related]
2. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
Front Immunol; 2022; 13():960733. PubMed ID: 35967323
[TBL] [Abstract][Full Text] [Related]
3. Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses.
Cramer J; Aliu B; Jiang X; Sharpe T; Pang L; Hadorn A; Rabbani S; Ernst B
ChemMedChem; 2021 Aug; 16(15):2345-2353. PubMed ID: 34061468
[TBL] [Abstract][Full Text] [Related]
4. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
Thépaut M; Luczkowiak J; Vivès C; Labiod N; Bally I; Lasala F; Grimoire Y; Fenel D; Sattin S; Thielens N; Schoehn G; Bernardi A; Delgado R; Fieschi F
PLoS Pathog; 2021 May; 17(5):e1009576. PubMed ID: 34015061
[TBL] [Abstract][Full Text] [Related]
5. Combating DC-SIGN-mediated SARS-CoV-2 dissemination by glycan-mimicking polymers.
Cramer J; Jiang X; Aliu B; Ernst B
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300396. PubMed ID: 38086006
[TBL] [Abstract][Full Text] [Related]
6. Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
Pollastri S; Delaunay C; Thépaut M; Fieschi F; Bernardi A
Chem Commun (Camb); 2022 Apr; 58(33):5136-5139. PubMed ID: 35380569
[TBL] [Abstract][Full Text] [Related]
7. C
Patino-Alonso J; Cabrera-González J; Merino J; Nieto-Ortiz G; Lasala F; Katati J; da Cruz CHB; Monnappa AK; Mateos-Gil P; Canales Á; López-Montero I; Illescas BM; Delgado R; Martín N
Small; 2024 May; 20(19):e2307045. PubMed ID: 38100142
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
9. The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells.
Johnson EL; Ohkawa Y; Kanto N; Fujinawa R; Kuribara T; Miyoshi E; Taniguchi N
Cell Stress Chaperones; 2024 Apr; 29(2):227-234. PubMed ID: 38453000
[TBL] [Abstract][Full Text] [Related]
10. The role of DC-SIGN as a trans-receptor in infection by MERS-CoV.
Labiod N; Luczkowiak J; Tapia MM; Lasala F; Delgado R
Front Cell Infect Microbiol; 2023; 13():1177270. PubMed ID: 37808906
[TBL] [Abstract][Full Text] [Related]
11. Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.
Sutkeviciute I; Thépaut M; Sattin S; Berzi A; McGeagh J; Grudinin S; Weiser J; Le Roy A; Reina JJ; Rojo J; Clerici M; Bernardi A; Ebel C; Fieschi F
ACS Chem Biol; 2014 Jun; 9(6):1377-85. PubMed ID: 24749535
[TBL] [Abstract][Full Text] [Related]
12. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.
Kondo Y; Larabee JL; Gao L; Shi H; Shao B; Hoover CM; McDaniel JM; Ho YC; Silasi-Mansat R; Archer-Hartmann SA; Azadi P; Srinivasan RS; Rezaie AR; Borczuk A; Laurence JC; Lupu F; Ahamed J; McEver RP; Papin JF; Yu Z; Xia L
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291736
[TBL] [Abstract][Full Text] [Related]
13. Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.
Prost LR; Grim JC; Tonelli M; Kiessling LL
ACS Chem Biol; 2012 Sep; 7(9):1603-8. PubMed ID: 22747463
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
15. New lipophilic glycomimetic DC-SIGN ligands: Stereoselective synthesis and SPR-based binding inhibition assays.
Di Pietro S; Bordoni V; Iacopini D; Achilli S; Pineschi M; Thépaut M; Fieschi F; Crotti P; Di Bussolo V
Bioorg Chem; 2021 Feb; 107():104566. PubMed ID: 33387733
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering.
Guzzi C; Alfarano P; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Fieschi F; Bernardi A; Weiser J; Rojo J; Angulo J; Nieto PM
Org Biomol Chem; 2016 Jan; 14(1):335-44. PubMed ID: 26611567
[TBL] [Abstract][Full Text] [Related]
17. Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.
Taouai M; Porkolab V; Chakroun K; Cheneau C; Luczkowiak J; Abidi R; Lesur D; Cragg PJ; Halary F; Delgado R; Fieschi F; Benazza M
Bioconjug Chem; 2019 Apr; 30(4):1114-1126. PubMed ID: 30912645
[TBL] [Abstract][Full Text] [Related]
18. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
[TBL] [Abstract][Full Text] [Related]
19. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.
Spear GT; Zariffard MR; Xin J; Saifuddin M
Immunology; 2003 Sep; 110(1):80-5. PubMed ID: 12941144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
